Atropine test and circulatory arrest in the fossa posterior assessed by transcranial Doppler

被引:17
作者
Hüttemann, E [1 ]
Schelenz, C [1 ]
Sakka, SG [1 ]
Reinhart, K [1 ]
机构
[1] Univ Jena, Dept Anaesthesiol & Intens Care Med, D-07740 Jena, Germany
关键词
atropine test; transcranial; Doppler; brain death;
D O I
10.1007/s001340051176
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To evaluate whether a negative atropine test (i.e., increase in heart rate of less than 3 % after intravenous administration of 3 mg atropine) correctly predicts circulatory arrest in the fossa posterior during craniocaudal herniation in patients with primary supratentorial lesions. Materials and methods: Prospective, observational clinical study. Setting: Two surgical intensive care units in a university hospital. Patients: In 45 consecutive patients with suspected brain death, an atropine test (AT) and a transcranial Doppler sonography were performed simultaneously and, if necessary, repeatedly. Measurements and results: Forty-four patients fulfilled the typical criteria of a supratentorial and infra- tentorial circulatory arrest as the atropine test became negative. In one patient, who had undergone a decompressive craniectomy for uncontrollable intracranial pressure 4 h prior to the AT testing, we found a negative AT in the presence of an antegrade supratentorial and infratentorial flow. Conclusion: A negative atropine test indicates a circulatory arrest in the fossa posterior in patients with primary supratentorial lesions and craniocaudal herniation. In patients with brain-stem lesions, however, a negative atropine test does not unequivocally indicate a circulatory arrest.
引用
收藏
页码:422 / 425
页数:4
相关论文
共 13 条
[1]  
Bundesarztekammer wissenschaftlicher Beirat, 1998, DTSCH ARZTEBLATT, V95, pA1861
[2]  
DAUCHOT P, 1971, CLIN PHARMACOL THER, V12, P274
[3]   ELECTROCARDIOGRAPHIC FINDINGS IN BRAIN DEATH - DESCRIPTION AND PRESUMED MECHANISM [J].
DRORY, Y ;
OUAKNINE, G ;
KOSARY, IZ ;
KELLERMANN, JJ .
CHEST, 1975, 67 (04) :425-432
[4]   TRANSCRANIAL DOPPLER AND BRAIN-DEATH DIAGNOSIS [J].
FERI, M ;
RALLI, L ;
FELICI, M ;
VANNI, D ;
CAPRIA, V .
CRITICAL CARE MEDICINE, 1994, 22 (07) :1120-1126
[5]   INTEGRATED PHARMACOKINETICS AND PHARMACODYNAMICS OF ATROPINE IN HEALTHY HUMANS .1. PHARMACOKINETICS [J].
HINDERLING, PH ;
GUNDERTREMY, U ;
SCHMIDLIN, O .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (07) :703-710
[6]   INTEGRATED PHARMACOKINETICS AND PHARMACODYNAMICS OF ATROPINE IN HEALTHY HUMANS .2. PHARMACODYNAMICS [J].
HINDERLING, PH ;
GUNDERTREMY, U ;
SCHMIDLIN, O ;
HEINZEL, G .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (07) :711-717
[7]   RELIABILITY IN DIAGNOSIS OF BRAIN-DEATH [J].
PAOLIN, A ;
MANUALI, A ;
DIPAOLA, F ;
BOCCALETTO, F ;
CAPUTO, P ;
ZANATA, R ;
BARDIN, GP ;
SIMINI, G .
INTENSIVE CARE MEDICINE, 1995, 21 (08) :657-662
[8]   THE ROLE OF TRANSCRANIAL DOPPLER IN CONFIRMING BRAIN-DEATH - SENSITIVITY, SPECIFICITY, AND SUGGESTIONS FOR PERFORMANCE AND INTERPRETATION [J].
PETTY, GW ;
MOHR, JP ;
PEDLEY, TA ;
TATEMICHI, TK ;
LENNIHAN, L ;
DUTERTE, DI ;
SACCO, RL .
NEUROLOGY, 1990, 40 (02) :300-303
[9]  
QUAKNINE GE, 1973, J NEUROSURG, V39, P429
[10]  
QUAKNINE GE, 1975, RESUSCITATION, V4, P159